Background The high prevalence of atrial fibrillation (AF) and its association with cardiovascular (CV) outcomes represent a ...
Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma’s ...
Rival treatments had mixed results in the past AstraZeneca sees $3-5 billion peak annual sales for its drug Detailed results to be presented at upcoming medical conference Shares among biggest gainers ...
Artificial untelligence (AI) stocks under $10 are publicly traded companies developing or applying AI technologies, with stock prices below $10 per share. These lower-priced AI stocks can present ...
Background Cancer survivors often face the risk of developing heart failure (HF) as a result of their previous cancer therapy ...
Get personalized, AI-powered answers built on 27+ years of trusted expertise. "Affluent," according to Visa Inc. (V), means being the top 10%. According to the company's November 2025 report, the top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results